(19)
(11) EP 4 486 348 A1

(12)

(43) Date of publication:
08.01.2025 Bulletin 2025/02

(21) Application number: 23707768.0

(22) Date of filing: 02.03.2023
(51) International Patent Classification (IPC): 
A61K 31/506(2006.01)
A61K 31/585(2006.01)
A61P 35/00(2006.01)
A61K 31/5377(2006.01)
C07D 401/12(2006.01)
C07D 413/12(2006.01)
A61K 31/4045(2006.01)
A61K 45/06(2006.01)
A61K 31/505(2006.01)
C07D 239/48(2006.01)
C07D 403/12(2006.01)
C07D 417/14(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 35/00; A61K 31/506; A61K 31/4045; A61K 31/585; A61K 45/06; A61K 31/505; A61K 31/5377; C07D 239/48; C07D 401/12; C07D 403/12; C07D 413/12; C07D 417/14
 
C-Sets:
  1. A61K 31/5377, A61K 2300/00;
  2. A61K 31/4045, A61K 2300/00;
  3. A61K 31/585, A61K 2300/00;
  4. A61K 31/506, A61K 2300/00;
  5. A61K 31/505, A61K 2300/00;

(86) International application number:
PCT/EP2023/055381
(87) International publication number:
WO 2023/166153 (07.09.2023 Gazette 2023/36)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 02.03.2022 EP 22159838

(71) Applicant: Trustlife Global Inc.
San Diego, CA 92101 (US)

(72) Inventors:
  • LI, Xiangyu
    113 46 Stockholm (SE)
  • BOUZIAN, Younos
    34774 Ümraniye/Istanbul (TR)
  • EL HAFI, Mohamed
    34774 Ümraniye/Istanbul (TR)
  • PARVIZI, Negar
    34774 Ümraniye/Istanbul (TR)
  • MARDINOGLU, Adil
    412 60 Göteborg (SE)

(74) Representative: Kransell & Wennborg KB 
P.O. Box 27834
115 93 Stockholm
115 93 Stockholm (SE)

   


(54) NEW COMPOUNDS AND TREATMENT OF RENAL CELL CARCINOMA